Illumina appoints Ragusa as CEO of Grail

2021 01 27 00 33 2291 Genome Sequence Barcode 400

Illumina has appointed Bob Ragusa as CEO of Grail, which currently operates as a separate and independent unit of Illumina after its August acquisition.

Ragusa succeeds Hans Bishop, who will continue to serve as advisor to the CEO through the end of 2021.

Ragusa has over 30 years of experience in genomics. He was previously Illumina's chief operating officer, where he was responsible for scaling the business to serve over 7,000 customers in more than 140 countries, the company said.

Ragusa holds a Master of Science in biomedical and electrical engineering from Carnegie Mellon University, as well as a Bachelor of Science in electrical engineering and a Master of Business Administration from the University of Connecticut.

Page 1 of 164
Next Page